Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
Sign in with Google
ENTITY
Viva Biotech Holdings (1873 HK)
Watchlist
73
Analysis
Health Care
•
China
Viva Biotech Holdings operates as a drug discovery platform. The Company provides target protein expression, structure researching, hit screening, drug candidate determination, and other services. Viva Biotech Holdings serves customers worldwide.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
Quantitative Analysis
•
17 Sep 2023 02:10
Hong Kong Connect Flows (Sep 15th): ICBC, Innovent Biologics, CCB, Sunac China
We analyzed southbound Hong Kong connect flows in the past week and highlight flows for ICBC, Innovent Biologics, CCB, Sunac China.
Ke Yan, CFA, FRM
Follow
479 Views
Share
bearish
•
Quantitative Analysis
•
10 Sep 2023 02:10
Hong Kong Connect Flows (Sep 8th): ICBC, CNOOC, CCB, HKEx, China Petroleum & Chemical
We analyzed the Hong Kong Connect Scheme for last week and highlight flows for ICBC, CNOOC, CCB, HKEx, China Petroleum & Chemical.
Ke Yan, CFA, FRM
Follow
573 Views
Share
bullish
•
Brilliance China Automotive
•
19 Aug 2023 23:19
Index Rebalance & ETF Flow Recap: ASX, NEXT50, MVMVA, MVMVW, Celltrion, Brilliance, KQ150, HSCI
This recap highlights Insights covering Asian index rebalances (announcements/ forecasts/ IPO Fast Entry/ M&A driven changes). We also highlight...
Brian Freitas
Follow
511 Views
Share
bullish
•
ZJLD Group
•
19 Aug 2023 04:21
HSCI Index Rebalance: 22 Adds, 27 Deletes & Changes to Southbound Stock Connect
There are 22 adds/ 27 deletes for the HSCI in Sep leading to 22 adds/ 24 deletes for Stock Connect. Since end June, shares held though Southbound...
Brian Freitas
Follow
727 Views
Share
bearish
•
Quantitative Analysis
•
30 Jul 2023 02:20
Hong Kong Connect Flows (Jul 28th): Kuaishou Technology, Tencent, HSBC
We analyzed southbound Hong Kong connect flows in the past week and highlight flows for Kuaishou Technology, Tencent, HSBC.
Ke Yan, CFA, FRM
Follow
358 Views
Share
Previous
1
2
3
4
5
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.52.0
x